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Summary: Real-time RT PCR has been recognized as an
accurate, reliable and sensitive method for quantifying gene
transcription. However, several steps preceding PCR repre-
sent critical points and source of inaccuracies. These steps
include cell processing, RNA extraction, RNA storage,
assessment of RNA concentration and cDNA synthesis. To
compensate for potential variability introduced by the proce-
dure, normalization of target gene expression has been
established. Accurate normalization has become an absolute
prerequisite for the correct quantification of gene expression.
Several strategies are in use for the normalization of data,
including normalization to sample size, to total RNA or to an
internal reference. Among these, the use of housekeeping
genes as an internal (endogenous) control is the most com-
mon approach. Given the increased sensitivity, reproducibili-
ty and large dynamic range of this methodology, the require-
ments for a proper reference gene for normalization have
become increasingly stringent. The aim of this paper is to
discuss the concept of normalization in mRNA quantifica-
tion, as well as to discuss several statistical algorithms devel-
oped to help the validation of potential reference genes. By
showing that the use of inappropriate endogenous control
might lead to incorrect results and misinterpretation of
experimental data, we are joining the creators of Minimum
Information for Publication of Quantitative Real-Time PCR
Experiments (MIQE) in an attempt to convince scientists that
proper validation of potential reference genes is an absolute
Kratak sadr`aj: RT-PCR je prepoznat kao precizna,
pouzdana i osetljiva metoda za kvantifikaciju transkripcije
gena. Me|utim, ovoj metodi prethodi nekoliko koraka koji
predstavljaju kriti~ne ta~ke i izvor potencijalnih gre{aka. Ovi
koraci uklju~uju obradu }elijskog materijala, ekstrakciju i
~uvanje RNK, odre|ivanje koncentracije RNK i sintezu
cDNK. Da bi se kompenzovala potencijalna varijabilnost na -
stala tokom procedure, uvedena je normalizacija ekspresije
ciljnih gena. Precizna normalizacija je postala apsolutni pre-
duslov za ta~nu kvantifikaciju ekspresije gena. Postoji neko-
liko strategija za normalizaciju eksperimentalnih podataka,
uklju~uju}i normalizaciju u odnosu na veli~inu uzorka, ukup-
nu RNK ili internu kontrolu (referencu). Kao interna (endo-
gena) kontrola naj~e{}e se koriste geni sa stabilnom ekspre-
sijom. Imaju}i u vidu veliku osetljivost, reproducibilnost i
ve liki dinami~ki opseg PCR metode, zahtevi za odgova ra -
ju}im referentnim genima koji }e se koristiti za normalizaciju
podataka postali su veoma restriktivni. Cilj ovog rada je da
razjasni koncept normalizacije i prokomentari{e nekoliko sta-
tisti~kih algoritama koji su razvijeni kako bi pomogli u valida -
ciji potencijalnih referentnih gena. Pokazuju}i da kori{}enje
neodgovaraju}ih referentnih gena (endogenih kontrola)
mo`e da dovede do neta~nih rezultata i pogre{ne inter-
pretacije eksperimentalnih podataka, mi se priklju~ujemo
tvorcima uputstva MIQE (eng. Minimum Information for
Publication of Quantitative Real-Time PCR Experiments) u
poku{aju da ubedimo nau~nu javnost da je ispravna validaci-
List of abbreviations: B2M, b2-microglobulin; BA, b-actin,
FRET, Fluorescence Resonance Energy Transfer; GAPDH,
Gly ceraldehydes-3-phosphate dehydrogenase; HPRT, Hypo -
xanthine phosphoribosyltransferase 1; MIQE, Minimum
Information for Publication of Quantitative Real-Time PCR
Experiments; PCR, Polymerase Chain Reaction; RT, reverse
transcription.
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Introduction to real-time RT PCR 
In 2013, the year of DNA anniversaries, we are
celebrating 60 years of Watson and Crick’s discovery
of the DNA structure, 40 years of the genetic modifi-
cation of bacteria using recombinant DNA, 30 years
of the invention of Polymerase Chain Reaction (PCR)
and 10 years of the announcement of the completion
of human genome sequencing. As for the PCR, in
addition to 30 years from its invention, this year it has
been 20 years since Mullis won the Nobel Prize for
PCR. 
Ever since its development, PCR is considered
an essential tool in molecular biology, allowing ampli-
fication of nucleic acid sequences (DNA and RNA)
through repetitive cycles in vitro. The mechanisms
underlying this methodology are similar to those occur -
ring in vivo during DNA replication. There are three
main sequentially repeating steps of PCR: denaturation,
annealing and elongation. Denatu ra tion, as the first
step that proceeds at high temperatures, serves to
separate DNA strands. In the annealing step, at a
lower temperature, each strand is used as a template
for DNA synthesis. The selectivity of PCR results is
achieved in this step by using the primers comple-
mentary to the sequences outlining the targeted DNA
region. During the elongation step, DNA polymerase
creates two double strand target regions, each of
which can again be denatured and ready for a second
cycle of annealing (hybridization) and elongation
(Figure 1).
If the reaction runs with 100% efficiency there
will be a two-fold increase in target amplicons after
each cycle of PCR. Therefore, after n cycles of reac-
tion, the copy number of the target sequence will be
2n. In practice, however, reactions do not work with
perfect efficiency, as reactants within the PCR mixture
are depleted after many cycles and the reaction
reaches a plateau phase, in which there is no change
in the amount of the product. Plateau phase is pre-
ceded by a linear ground phase, an exponential
phase and a log-linear phase (Figure 2). Only in the
exponential phase the quantity of PCR products is
proportional to the quantity of initial template. The
main disadvantage of conventional PCR, which is also
called end-point PCR, regarding the quantification, is
the fact that the results of amplification can be visual-
ized only after n cycles of amplification at the end of
the reaction.
In recent years, modifications of the convention-
al PCR method have been developed in order to
prerequisite for correct normalization and, therefore, for pro-
viding accurate and reliable data by quantitative real-time RT
PCR gene expression analyses.
Keywords: real-time PCR, reference gene, normalization,
validation, GeNorm, NormFinder, MIQE
ja potencijalnih referentnih gena apsolutni preduslov za
ta~nu normalizaciju i, shodno tome, preduslov za dobijanje
ta~nih i pouzdanih podataka u analizi ekspresije gena
metodom kvantitativnog PCR-a u realnom vremenu.
Klju~ne re~i: PCR u realnom vremenu, referentni gen,
normalizacija, validacija, GeNorm, NormFinder, MIQE
Figure 1 Phases of the Polymerase Chain Reaction (PCR).
Figure 2 PCR Amplification Plot.
improve its performance and specificity. One of them,
called real-time PCR or fluorescence based PCR,
enables us to collect data throughout the PCR
process, enabling quantification at a point in which
every sample is in the exponential phase of PCR reac-
tion, when reagents are in excess, product is doubling
at every cycle, and the product quantity positively cor-
relates with starting template quantity. Real-time PCR
allows us to quantitate nucleic acids from various
sources, to compare the variable states of infection, to
detect chromosomal translocations, to genotype sin-
gle nucleotide polymorphisms, to determine the gene
expression level. It is mostly used for two reasons:
either as a primary investigative tool to determine the
gene expression level, or as a secondary tool to vali-
date the results of DNA microarrays (1).
There are many advantages of using real-time
RT PCR instead of end-point PCR in gene expression
studies (Table I). First of all, it is a quantitative method
for the determination of gene expression, while end-
point PCR is semiquantitative. Real-time RT PCR col-
lects data during the exponential phase of the PCR
amplification process, in which the PCR reaction is
not limited by enzymatic activity or substrate concen-
tration, while in end-point PCR data are obtained at
the end of the reaction using usually agarose gels for
detection. Due to the ability of detection of fluores-
cent signals in »real-time« during each subsequent
PCR cycle, real-time RT PCR data can be obtained in
a short period of time and no post-PCR processing is
needed. Since no postamplification steps are re -
quired, the risk of PCR product contamination is dras-
tically reduced (2) and reliability and reproducibility of
the assay are increased (3, 4). In contrast to end-
point PCR, real-time RT PCR is automated, and data
analyses, including standard curve generation and
copy number calculation, are performed automatical-
ly. In general, it is less time- and labor-intensive, and
can be high throughput when using the proper equip-
ment. The major disadvantage of real-time RT PCR is
the expensive equipment and reagents relative to
those used in end-point PCR. In addition, due to its
extrem ely high sensitivity, the understanding and
proper implementation of nor malization strategies are
impe rative for accurate conclusions.
Detection chemistries
As mentioned before, in real-time RT PCR the
reaction products are quantitatively measured in
»real-time« during each PCR cycle (5). The method is
based on the detection and quantification of a fluo-
rescent signal, which increases proportionally to PCR
product accumulation. There are two types of detec-
tion chemistries that are used in real-time RT PCR,
designated specific and nonspecific. Specific se -
quence detection distinguishes the sequence of inte r -
est from primer dimers or nonspecific amplification,
whereas nonspecific detection registers all double-
stranded DNA produced during the reaction.
Nonspecific detection chemistry
SYBR Green. SYBR Green represents the sim-
plest and the most economical choice for real-time
RT PCR product detection (6). This fluorogenic inter-
calating dye emits a strong fluorescent signal upon
binding to double-stranded DNA while unbound dye
in solution exhibits little (undetectable) fluorescence
(Figure 3). There are several advantages of using
SYBR Green: it is the least expensive, simple and easy
to use. It can be used with any pair of primers, for any
target, with no need for any additional fluorescence-
labeled oligonucleotide. Therefore, it can be easily
applied to already established PCR assays, but for the
same reason it is not possible to perform multiplexing
reactions. The major disadvantage of using SYBER
Green is that both specific and nonspecific PCR prod-
ucts are detected. Namely, SYBR Green will bind to
any double-stranded DNA in the reaction, including
primer-dimers and other nonspecific reaction prod-
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Table I End-point PCR vs Real-time PCR.
End-point PCR Real-time PCR
Semiquantitative
Nonautomated
Needs post-PCR processing
Time-consuming
Low technical sensitivity 
Low precision
Short dynamic range 
Low resolution (detection of 10-fold change)
Possible cross contamination
No possibility for a multiplex approach
Quantitative
Automated
No post-PCR steps
Fast
High technical sensitivity
High precision
Wide dynamic range 
High resolution (detection of 2-fold change)
Minimized cross contamination
Multiplex approach possible
Incorporated specialized software for data analysis
High throughput
ucts, leading to overestimation of the target sequence
concentration (7). Therefore, this method requires
extensive optimization of the PCR conditions and a
clear differentiation between specific and nonspecific
PCR products using melting-curve analysis (8). 
Specific sequence detection chemistry 
In order to avoid major disadvantages of SYBR
Green, sequence specific, fluorescent primer/probe-
based chemistries have been developed. These
chemistries are based on the introduction of an addi-
tional fluorescence-labeled oligonucleotide – the
probe, and de pend on Fluorescence Resonance
Energy Transfer (FRET) (9). The most frequently used
sequence specific detection chemistries are: the
TaqMan hydrolysis probes, Molecular Beacons, dual
Hybridization Probes, and Scorpions (Figure 4). 
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Figure 3 Nonspecific detection chemistry: DNA-binding
dye – SYBR Green.
Figure 4 Specific sequence detection chemistries: TaqMan hydrolysis probes (A), Molecular Beacons (B), dual Hybridization
Probes (C), and Scorpions (D). 
In most cases, primer/probe chemistries are
designed to exploit FRET in quenching fluorescence
in order to ensure that specific fluorescence is detect-
ed only when the product of interest is amplified.
However, in some cases FRET is used to enhance the
signal, such as in the case of dual hybridization
probes, when fluorescence of donor dye excites the
acceptor dye, resulting in emission of detectable fluo-
rescence only when two fluorochromes are in close
proximity (10–14). 
The main advantage of primer/probe-based
chemistries is increased specificity, which no longer
depends only on primer binding (15). Nonspecific
amplification due to mispriming or primer–dimer arti-
facts does not generate a signal and is ignored by the
fluorescence detector. Another advantage of these
chemistries over intercalating dyes includes a possibil-
ity to perform multiplexing reactions (16). Namely,
using a different fluorophore on each gene-specific
probe allows the detection of amplification products
from several distinct sequences in a single PCR reac-
tion. The major advantage of primer/probe-based
chemistries is increased accuracy and specificity of
PCR product detection, achieved by precise, gene-
specific matching of usually three independent
nucleotide sequences, which practically eliminates
false positive results. However, these chemistries are
far more expensive in comparison to SYBR Green,
since each target requires its own specific probe.
Hydrolysis or TaqMan Probes. Hydrolysis assays
include three sequence-specific oligonucleotides: for-
ward primer, reverse primer, and a probe (17, 18).
The probe is labeled with a fluorescent reporter dye at
the 5’ end and a quencher dye at the 3’ end (Figure
4A). The assay exploits the 5’ → 3’ exonuclease activ-
ity of certain thermostabile enzymes, usually Taq or
Tht polymerase. When the probe is intact, the
quencher dye absorbs the fluorescence of the
reporter dye due to the proximity between them.
Upon amplification of the target sequence, the probe
is displaced and hydrolyzed by the 5’ → 3’ exonucle-
ase activity of the polymerase. Consequently, the
reporter is separated from the quencher, resulting in a
fluorescence signal that is proportional to the amount
of amplified product. During each PCR cycle, fluores-
cence will further increase due to progressive and
exponential accumulation of free reporter. 
Molecular Beacons. Real-time PCR assays with
molecular beacons also use three sequence-specific
oligonucleotides: forward primer, reverse primer, and
a probe (19). The probe is a »molecular beacon« – an
oligonucleotide labeled with a fluorescent reporter
dye at the 5’ end and a quencher dye at the 3’ end,
which forms a hairpin structure, thus bringing the
reporter and quencher together (Figure 4B). When
molecular beacon is free in solution, it forms a hair-
pin structure, so that the reporter and the quencher
are in close proximity and no fluorescence is emitted.
During the annealing step the probe undergoes a
conformational change and binds to target sequence.
The reporter and quencher are separated, and conse-
quently, quenching is abolished and the fluorescence
of reporter dye is emitted and detected. Unlike hydro -
lysis probes, molecular beacons are displaced, but not
destroyed during the PCR amplification.
Hybridization Probes. In real-time PCR analysis
with dual hybridization probes, four oligonucleotides
are used: two primers and two juxtaposed probes
(20). First probe is labeled with donor fluorophore at
the 3’ end, while the acceptor fluorophore is attached
to the 5’ end of the second probe (Figure 4C). The
probes hybridize in a head-to-tail orientation in close
vicinity to the target sequences, bringing the two flu-
orophores into close proximity and allowing FRET.
Excited donor fluorophore emits light that excites
acceptor dye, which dissipates fluorescence at a dif-
ferent wavelength. The reaction is monitored at the
emission wavelength of the acceptor fluorophore.
Since probes are not destroyed during the reaction,
after each PCR cycle more probes can anneal to tar-
get sequences, which results in higher fluorescence
signals. The amount of fluorescence is directly pro-
portional to the amount of target DNA generated dur-
ing the PCR process. 
Scorpions. These reactions use two oligonu-
cleotides: a primer and a bi-functional Scorpion that
combines the upstream primer with a hairpin–loop
probe labeled with a reporter dye at the 5’ end and a
quencher dye at the 3’ end (21). This configuration
brings the fluorophore in close proximity with the
quencher and avoids fluorescence (Figure 4D).
During PCR, the Scorpion primer is extended at its 3’
end; the loop sequence of Scorpion hybridizes to
newly synthesized target within the same strand of the
PCR product. The fluorophore and the quencher are
separated, leading to emission of fluorescence. Scor -
pion probe contains a PCR blocker, which prevents
DNA polymerase to read-through Scorpion primer
and copy the probe region during the extension of the
opposite strand. Moreover, in comparison with molec-
ular beacons and TaqMan probes, Scorpions are
faster and are able to produce a much stronger fluo-
rescence signal, since they are based on kinetically
more favorable unimolecular rearrangements (22).
In addition, many other fluorescence based
chemistries are developed (LUX fluorogenic primers,
amplifluor assays, QZyme primers, Light-Up probes,
eclipse probes, Pleiades), and new designs are still
being proposed (23–30). These assays are expected
to be more adopted in the future.
All previously discussed chemistries can deliver
excellent results, and each has its advantages and dis-
advantages (31). They all require less RNA than end-
point assays and are particularly suitable when work-
ing with small amounts of starting material; also, they
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are more precise and more resistant to nonspecific
amplification. The choice of detection chemistry is
highly dependent on the characteristics of each indi-
vidual experiment. Among many available primer/
probe-based chemistries, in our opinion, TaqMan
probes have proven to be well established and at this
moment may be the best choice for gene expression
studies. This opinion is supported by an exponentially
increasing number of publications, showing that the
results obtained by TaqMan chemistry are very specif-
ic and sensitive, which appears to be particularly
important when analyzing target genes with very low
expression levels. Moreover, this system has very well
written guidelines and protocols, and is fairly error
proof when designed and run according to protocol.
On the other hand, Molecular Beacons and Scorpions
are especially suitable for identifying point mutations. 
Normalization of real-time RT PCR data
Real-time RT PCR has become a method of
choice for the investigation of gene expression in bio-
medical research (32, 33). Nevertheless, a number of
problems are still associated with its use (34–36).
Importantly, the improper use of this technique as a
clinical tool might have significant public health impli-
cations (37). Therefore, it is important to clearly point
to some disadvantages of the current methods and to
the critical steps that need to be carefully considered
in experimental design. The reliability of real-time RT
PCR results depends on the precision of many steps
during the experimental procedure, from sample
acquisition, preparation, handling and storage (38,
39), to reverse transcription (40), specific amplifica-
tion (35), and data analysis (34, 35, 39, 41, 42).
Nevertheless, variations in the amount of starting
material, together with other potential experimental
inaccuracies can be corrected by the normalization of
target gene expression (43). Therefore, one of the
most important steps in real-time RT PCR is the
choice of an appropriate normalization strategy.
There are several strategies that should be considered
for the normalization of real-time RT PCR data (36,
43, 44). 
The easiest, yet most intuitive, method for nor-
malization is equalizing initial sample size by using a
similar cell number, tissue volume or weight.
Although it is a good practice to always use similar
sized samples (e.g. a similar number of cultured cells,
or similar sized biopsy), applying this method as an
exclusive normalization strategy is insufficient be -
cause it does not account for the cumulative errors
that can occur in cDNA preparation. Moreover, in
some cases similar tissue volumes (blood, for exam-
ple), or weights (such as adipose tissue) do not con-
tain the same cellular material (types of blood cells or
cell number in case of adipocytes). Therefore, using
solely this approach for normalization can be mislead-
ing. 
The second method is normalization to total
RNA content after the extraction. Such normalization
has also been advocated as unreliable since the total
RNA content is usually determined spectrophotomet-
rically. An alternative, more sensitive and accurate
determination can be achieved by using the dye
RiboGreen. RNA quantification using a Bioanalyzer
(Agilent) represents a useful, but time–consuming
step. This analysis provides useful information about
the quality of the RNA, but again does not account
for the cumulative errors that can occur in cDNA
preparation. Namely, normalization to total RNA does
not take into account reverse transcription efficiency.
Finally, total RNA consists predominantly of rRNA,
and hence is not always representative of the mRNA
fraction. 
Normalizing to genomic DNA can be an effec-
tive strategy in some cases, but it is generally imprac-
tical since most RNA preparation protocols deliber-
ately eliminate the presence of DNA.
Normalizing to an artificial RNA molecule has
many advantages over commonly used methods (45).
Since this synthetic RNA should be included at a
known concentration during the extraction stage, it
will be affected and prone to the same experimental
errors as RNA of interest. Spiking RNA with an artifi-
cial RNA molecule at a known concentration has
been suggested as a method to normalize the errors
that occur during cDNA preparation. However, this
approach does not provide normalization for the actu-
al concentration of sample cDNA. Stability of the
spiked nucleic acid can also emerge as a problem.
Finally, generating artificial RNAs might be impracti-
cal for small laboratories, while commercially avail-
able standards increase the costs of the experiments. 
Normalizing to a stably expressed reference
(housekeeping) gene that is representative of the
cDNA concentration in a sample is the most com-
monly used normalization approach. The reference
(housekeeping) gene is subject to the same errors in
cDNA preparation as the gene of interest, thus being
an excellent normalizing control. However, careful
and strategic selection of the most stably expressed
reference gene is essential (46–48). Random selec-
tion of a reference gene can add large and unpre-
dictable errors to the analysis (49, 50).
There is no universally accepted strategy for nor-
malization, as there is no error-free procedure. Since
the mentioned approaches do not exclude each
other, the best way to ensure the precision, repeata-
bility and the reliability of the results (Figure 5) is to
equalize sample sizes, ensure similar input of RNA for
reverse transcription and measure internal control
(reference gene or artificial molecule).
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Housekeeping genes as reference
genes
Although several alternative normalization pro-
cedures were proposed (43), the most commonly
used strategy is normalization to an internal reference
or a housekeeping gene. The term housekeeping
gene was initially used for all genes that are essential
for the function of each cell. Housekeeping genes are
widely used as reference genes since their expression
is assumed to be stable. However, the presumption of
their invariable expression has been clearly discredit-
ed by a number of papers. Namely, numerous studies
imply that the expression of housekeeping genes
varies in response to treatment (47, 51), pathological
(52), or environmental conditions (53), nutritional
sta tus (54), ageing (55, 56) and developmental
stages (57, 58), as well as between sexes (59, 60),
tissue types (48, 61, 62) and cell lines (63). So the
search for an ideal reference gene began. 
The ideal reference gene was supposed to fulfill
several requirements: it must be constitutively
expressed and unregulated regarding the experimen-
tal conditions, treatment, stage of the disease, age,
gender etc. Preferably, it should be expressed at a
similar level as the target gene (36, 47). It appeared
that the search for such a gene was a search for the
Holy Grail. Numerous studies were performed in
order to test potential candidates, either by compar-
ing their expression in various tissues and organs, in
both sexes, by applying different drugs and other sub-
stances, or by examining their expression in various
diseases. All these results together made a giant step
forward in solving the problem of the perfect refer-
ence gene and pointed to a crucial finding: there is
no single ideal reference that can be universally
applied in all experimental designs. On the other
hand, they pointed to a simple solution of the prob-
lem: reference genes must be chosen specifically for
each experiment. Thus, the goal of the researchers
became to identify the most reliable reference gene
or a set of genes for every particular experiment. 
The 18S RNA, b-Actin (BA), glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), beta-2-micro -
globulin (B2M), hypoxanthine phosphoribosyltrans-
ferase 1 (HPRT1), TATA box binding protein (TBP),
beta-glucuronidase (GUSB), RNA polymerase II (RPII
or POLR2A), tyrosine-3 monooxygenase/tryptophan-
5 monooxygenase activation protein, zeta polypeptide
(YWHAZ) and ubiquitin C (UBC) are some of the
most commonly used reference genes in real-time RT
PCR studies, although the issue of using these genes
for normalization is a matter of constant debate.
Namely, apart from their basic cellular roles, these
proteins also participate in other cellular functions.
Consequently, numerous studies demonstrated vari-
ability in the level of expression of these genes under
various experimental conditions. Nevertheless, there
is also evidence favoring their use, either se parately or
in various combinations, as appropriate internal stan-
dards in a number of carefully defined con ditions,
thus supporting the concept of proper vali dation for
every single experimental design. Worryingly, this is
still not a widely appreciated or acknowledged
instruction. Unfortunately, the majority of studies
applied reference genes without previous evaluation
of their suitability for the specific experimental model.
GAPDH is one of the most commonly used ref-
erence genes, but its use as a reference gene for
quantitative PCR analysis has been extensively debat-
ed (36, 46). GAPDH has been well known as a gly-
colytic enzyme. However, its role beyond glycolysis is
increasingly elucidated, as it appeared to be involved
in many other cellular processes, including DNA
repair, nuclear RNA export, transcriptional and post-
transcriptional regulation of gene expression, vesicu-
lar transport, receptor mediated cell signaling, mem-
brane fusion and transport, cytoskeletal dynamics and
cell death (64, 65). Participation in multiple pathways
of homeostatic regulation indicates that GAPDH may
have a fundamental role in a variety of pathologies
including diabetes, cancer, malaria and neurodegen-
erative disorders, such as Huntington’s, Parkinson’s
and Alzheimer’s disease. Therefore, GAPDH should
be considered as a reference gene only after proper
validation in every given experimental design.
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Figure 5 Real-time PCR workflow: critical steps and nor-
malization strategies.
Similarly to GAPDH, BA is one of the most com-
monly used reference genes whose reliability is fre-
quently questioned based on the new experimental
data. BA is a member of a multigene family. It is one
of the major components of cytoplasmic microfila-
ments and it plays an important role in cytoplasmic
steaming, cell motility, cell division, phagocytosis,
changing the cell shape, contraction of muscle cells,
etc. (66, 67). Although there are cases when BA can
be used as a reference gene (68, 69), it is not advis-
able to use it in situations when a tissue undergoes
extensive morphological changes, as expected in dif-
ferent developmental stages, or in rapidly growing tis-
sues, such as cancers. 
Phosphoglycerate kinase (PGK) 1 is an ATP-
gen e rating glycolytic enzyme that forms part of the
glycolytic pathway. Though it is often included as an
endogenous control in commercially available kits for
relative quantification of gene expression, this gene
should be widely avoided when cancer tissues are
analyzed because it is known to be involved in the
onset and development of different malignancies
(70).
By definition, a good internal control has a con-
stant expression level across the set of samples being
studied. The 18S rRNA has a low turnover rate, while
the large 18S rRNA pool is less prone to substantial
changes elicited by physiological perturbations.
Therefore, the 18S rRNA gene may be a useful inter-
nal control in gene expression studies. Its use has
been validated by numerous studies that showed its
invariant expression across various organisms, tissues,
developmental stages, and treatments (36, 71). How -
ever, there are two practical disadvantages in using
18S rRNA as a reference gene. First, having no
poly(A) tail, 18S rRNA is absent from purified mRNA
samples and is traditionally reverse transcribed with
either specific primers or random hexamers (72, 73).
Second, 18S rRNA is much more abundant than any
typical mRNA transcript and therefore must be dilut-
ed to obtain a threshold value within the dynamic
range of real-time PCR instruments, which inevitably
introduces variability to the measurement. However,
our results have shown that 18S rRNA can be suc-
cessfully reverse transcribed using poly(dT)18 with
lower efficiency in comparison to specific or random
primers, providing a way for its potential use as a ref -
erence gene (74).
B2M is a small subunit of the MHC class I mol-
ecule, and it has been successfully used as the refe -
rence gene in various experimental designs. However,
its altered expression has been demonstrated in vari-
ous pathophysiologies including different types of
cancers. More importantly, B2M is considered a dis-
criminatory biomarker and a good predictor, as well
as a potential therapeutic target in numerous patho-
physiological states, such as chronic kidney disease,
peripheral and coronary artery disease, ovarian can-
cer, multiple myeloma (75–77). Therefore, this gene
could be used as a reference gene with caution; in
other words, its use should be experimentally evalu -
ated.
HPRT is an enzyme involved in nucleotide meta -
bolism and it represents one of the housekeeping
genes expressed at a low level. It is advisable, there-
fore, to consider it as a reference gene in the experi-
ments with low abundance target genes. 
In order to find the best possible reference gene,
some new, not commonly used genes should be
included in the evaluation studies. A good example is
importin 8 (IPO8), which exhibits excellent expression
stability and shows no differences between normal
and malignant lung samples (78). At this time point,
several laboratories are in search for novel candidate
reference genes that will meet the criteria of an invari-
ant reference gene as closely as possible (79).
Statistical algorithms used for validation
of reference genes
Validation of reference genes represents a time-
consuming and expensive procedure, yet the use of
nonvalidated genes may result in incorrect data.
Several groups have developed statistical models and
software programs for the analysis of candidate gene
stability in order to help identifying the best reference
genes (62, 80, 81).
GeNorm, developed by Vandesompele and co -
workers, is among the most popular softwares (62).
This software makes pairwise comparison between
one and all other potential reference genes, in all
samples, regardless of the sample groups and exper-
imental conditions. The software ranks reference
gene stability by the average expression stability
value. It also analyzes pairwise variation values
between two sequential normalization factors (geo-
metric means of the best reference genes). Nor ma -
lization factors are calculated by stepwise inclusion of
an extra, less stable reference gene, to determine
how many reference genes should be used. The
authors strongly recommend using at least three ref-
erence genes for normalization, as a way to increase
the accuracy of the results and to reach the sensitivi-
ty needed for detection of subtle changes in the tar-
get gene expression. Never theless, performing nor-
malization by using the geometric mean of several
reference genes increases the costs and the quantity
of starting biological material and, therefore, is not
always the most convenient solution.
Although the pairwise comparison approach
emplo yed by GeNorm represents an authoritative
method for the analysis of potential reference genes,
it is important to be aware that it ranks genes accord-
ing to the similarity of their expression profiles, rather
than minimal variation. Another frequently used soft-
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ware is NormFinder (80). It is an application for
Microsoft Excel, which provides information on intra-
and inter-group variability and chooses the best refer-
ence gene, as well as the best combination of two ref-
erence genes. NormFinder, with its account of sample
groups and its direct estimation of expression varia-
tion, provides even more precise and robust measure-
ment of gene expression stability and, most impor-
tantly, candidate coregulation does not significantly
affect the approach. Therefore, the best way to iden-
tify the most stable reference gene/s is to use both
softwares. Besides these two, BestKeeper is also com-
monly used software for selection of reference genes.
It employs pairwise correlation analysis of candidate
reference genes and calculates the geometric mean
of the best suited ones (81).
Inaccurate interpretation of data
The time-consuming process of data analysis
during the selection of suitable reference genes can
be signi ficantly simplified by using the algorithms like
ge Norm, NormFinder and BestKeeper. Surprisingly,
these approaches are still underutilized. Instead, the
majority of reported research on gene expression
analysis uses traditional housekeeping genes as refer-
ences without any validation. Although considerable
efforts were made to encourage the use of validated
references in real-time RT PCR experiments, so far
their use and justification are still not obligatory for
publication in all journals.
Even though it is well documented that using
unstable reference genes can lead to incorrect results
(49, 50, 82, 83), the importance of this issue does
not seem to be fully realized. Namely, continuous use
of inappropriate reference genes increases the risk of
reporting erroneous and conflicting results that might
further affect data interpretation in basic and biomed-
ical research, with particularly appalling implications
in diagnostics, disease monitoring or drug develop-
ment (37). 
In 2009, Guenin et al. (50) elegantly illustrated
how easily misinterpretation of the results could arise
from the use of an inappropriate reference gene, by
reevaluation of the expression stability of a set of 14
reference genes in 2 different experimental setups. In
line with these results, our previous studies also
showed that the use of inappropriate reference for
normalization can lead to under- or overestimation of
the target gene expression level and to misinterpreta-
tion of the results (55, 84). 
In order to highlight the importance of endoge-
nous control selection, and point to the extent to
which the use of an invalid reference gene could
affect the results of real-time RT PCR analysis, herein
we assessed the expression of gap43 as a target gene
6, 12 and 18 months after treatment. The expression
of gap43 was normalized to a stable reference gene
(reference gene 1, GAPDH) and to an unsuitable ref -
er ence gene (reference gene 2, 18S rRNA). As
shown in Figure 6, strikingly different patterns of the
gap43 expression level were noticed after normaliza-
tion to GAPDH, as compared to normalization to 18S
rRNA. Consequently, an erroneous conclusion that
the gap43 expression level 12 and 18 months after
treatment decreases by 50% as compared to the 6-
month time point could be drawn based on incorrect
normalization, while in reality, a 5-fold increase in the
gap43 expression level occurs.
MIQE guidelines
In order to minimize possible future misinterpre-
tations, inconsistencies and discrepancies in the pub-
lished results, as well as to bring order into the termi -
nology and in the manner of describing procedures
and reagents, several leading scientists published
MIQE guidelines (Minimum Information for Publi -
cation of Quantitative Real-Time PCR Expe riments)
(85). It is a set of guidelines that provides the infor-
mation necessary for evaluation of real-time RT PCR
experiments, aiming to contribute to the accuracy and
reproducibility of published articles. MIQE guidelines
address some of the crucial steps in real-time RT
PCR, such as sample acquisition, RNA isolation,
reverse transcription and PCR reaction. It points to
critical information that should be incorporated in the
Material and Methods section, thus helping editors
and reviewers to evaluate the technical quality of the
submitted manuscripts (85–88).
For researchers, the MIQE checklist represents a
good starting point. It helps investigators to wisely
plan and conduct experiments, as well as to clearly
write and present the results (Figure 7) (89, 90).
Namely, it is important to provide complete technical
information in a manuscript, to validate protocols and
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Figure 6 Relative expression of gap43 measured 6, 12
and 18 months after a treatment and normalized to refer-
ence gene 1 and reference gene 2.
to present results and conclusions on the basis of
appropriate methods of analysis. 
In brief, to minimize possible misinterpretations
and to assure good biological reproducibility for the
published data, it is important to clearly define exper-
imental conditions and experimental groups (controls
vs. treatment/disease, etc), to accurately describe the
sample (tissue/organ, biopsy, cell line), as well as to
provide information on the type and number of repli-
cates, experimental procedures and chemistry. When
working with human samples, special care should
be taken during the preanalytical phase. A detailed
description of the possible errors during sample col-
lection, transportation, reception, handling and stor-
age in the laboratory is reviewed by Majki}-Singh and
[umarac (91). Samples should be stored frozen at a
temperature not higher than –70 °C until use. It is
important to report in detail where the sample was
obtained and whether it was processed immediately
or preserved (how long and under what conditions it
was stored). The RNA extraction method should be
stated and if a DNase treatment step is included, it is
essential to report the type of DNase used and the
reaction conditions. The extracted RNA should be
highly pure and undegraded. The use of degraded
RNA increases variability and can generate false
results, while impurities may lead to inhibition of the
reverse transcription and PCR reactions, which also
leads to varying and incorrect quantification of the
results. Therefore, the amount, quality and integrity
of RNA must be recorded. Since the RNases are
highly abundant in the environment, it is good to per-
form the reverse transcription of total RNA to a more
stable molecule – cDNA, immediately after the quali-
ty check. The reverse transcription is probably the
most variable step (92). Therefore, it is essential to
provide a detailed description of the protocol and
reagents used, including the amount of RNA reverse
transcribed, priming strategy, enzyme type, volume,
temperature, and duration of the reverse transcription
step. It is advisable to use the same amount of total
RNA for reverse transcription for all samples, in order
to minimize variability between biological replicates.
cDNA should be stored frozen at a temperature not
higher than –20 °C until use. For description of real-
time PCR, target accession numbers, amplicon loca-
tions and sizes, primer and probe (if used) sequences
(or commercial assay catalogue numbers), experi-
mental conditions and the manufacturer of a PCR
instrument should be listed together with the informa-
tion regarding melting curve analyses (for DNA bind-
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Figure 7 Information necessary for evaluation of real-time RT PCR experiments.
ing dye assays), PCR efficiency, linear dynamic range,
limits of detection and precision. It is a good practice
to include »inter-run calibrators« e.g. to run one iden-
tical sample on different plates, in order to allow
plate-to-plate comparison as well as measurement of
inter-run variation. »No template controls« should be
included on each plate for each gene, since they pro-
vide information about PCR contamination. Finally, it
is important to justify the choice of the used reference
gene and provide detailed information on the meth-
ods of data analysis and confidence estimation, to -
gether with specification of the software used.
In general, it is important to work under tightly
controlled and well-defined conditions, since the vari-
ability of results obtained from identical samples
assayed in different laboratories continues to be a
problem (93). Also, it is important to report all mea -
sured parameters and to list the chemistry used, as
well as the conditions for all reactions.
By following the precise MIQE guidelines, with a
well-designed and carefully performed experiment
and a good normalization strategy, real-time RT PCR
becomes a sensitive, efficient and reproducible
method for mea suring gene expression that guaran-
tees reliable data. 
Conclusion
Quantitative real-time RT PCR significantly sim-
plifies and accelerates the process of producing
reproducible and reliable quantification of target
genes transcription. Proper normalization is an abso -
lute prerequisite for reliable mRNA quantification.
There are several strategies that can be used for nor-
malizing real-time RT PCR data. These strategies are
not mutually exclusive, but at the moment, using ref-
erence genes represents the most acceptable strate-
gy, because it is simple to use and can provide con-
trol for every stage of the real-time PCR. However, it
must be used with caution. The key to normalization
when using this strategy is to be able to demonstrate
that it is valid. Therefore, the selection of suitable ref-
erence gene(s) is one of the most important steps. We
strongly recommend using validated reference genes
rather than relying on traditional housekeeping
genes. Realizing the full potential of real-time RT PCR
and its advantages over related conventional tech-
niques, together with adopting the systematic valida-
tion of reference genes as a prerequisite, would great-
ly improve the accuracy and consistency of the
published results. Finally, to ensure the relevance,
accuracy and correctness in the interpretation of data,
we encourage precise following of the MIQE guide-
lines. Adopting MIQE guidelines and including a
detailed description of sample acquisition and han-
dling, together with a full description of the PCR con-
ditions, chemistry and data analysis, will promote
experimental transparency, repeatability, accuracy
and relevance, and consequently help in ensuring
consistency of the results between laboratories.
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